Immunology and immunotherapy of cholangiocarcinoma is a research paper published in Nature Reviews Gastroenterology & Hepatology (2023). On theSindex it has a DataRank of 0.787. It has been cited 189 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.787
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Intramural NIH HHS
Grant: ZIA BC011345
Intramural NIH HHS
Grant: ZIA BC010313
NIDDK NIH HHS
Grant: P30 DK132710
NCI NIH HHS
Grant: P50 CA127003
NCI NIH HHS
Grant: R01 CA228483
Intramural NIH HHS
Grant: Z01 BC010313
National Institutes of Health
Grant: 5P50CA127003-12
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
National Institutes of Health
Grant: 5R01CA228483-03
Role of Cancer-Associated Fibroblasts in Cholangiocarcinoma
National Institutes of Health
Grant: 1P30DK132710-01
The Columbia University Digestive and Liver Disease Research Center
FWCI
49.97
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals